StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Skinvisible's ebitda for the twelve months ending Jun 30, 2026 was -$438.74K. For fiscal 2025 it was -$476.08K. The highest annual figure on record is $206.02K in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$476.08K–
FY2024Dec 31, 2024-$569.15K–
FY2023Dec 31, 2023-$471.60K–
FY2022Dec 31, 2022-$219.69K-206.6%
FY2021Dec 31, 2021$206.02K–
FY2020Dec 31, 2020-$221.64K–
FY2019Dec 31, 2019-$500.16K–
FY2018Dec 31, 2018-$558.96K–
FY2017Dec 31, 2017-$309.74K–
FY2016Dec 31, 2016-$784.06K–
FY2015Dec 31, 2015-$1.02M–
FY2014Dec 31, 2014-$1.13M–
FY2013Dec 31, 2013-$722.33K–
FY2012Dec 31, 2012-$1.27M–
FY2011Dec 31, 2011-$1.17M–
FY2010Dec 31, 2010-$758.31K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$107.82K–
Q1 FY2026Mar 31, 2026-$120.93K–
Q4 FY2025Dec 31, 2025-$109.05K–
Q3 FY2025Sep 30, 2025-$100.94K–
Q2 FY2025Jun 30, 2025-$131.17K–
Q1 FY2025Mar 31, 2025-$134.91K–
Q4 FY2024Dec 31, 2024-$193.69K–
Q3 FY2024Sep 30, 2024-$119.03K–
Q2 FY2024Jun 30, 2024-$137.94K–
Q1 FY2024Mar 31, 2024-$118.49K–
Q4 FY2023Dec 31, 2023-$131.79K–
Q3 FY2023Sep 30, 2023-$108.57K–
Q2 FY2023Jun 30, 2023-$107.98K-170.9%
Q1 FY2023Mar 31, 2023-$123.26K–
Q4 FY2022Dec 31, 2022-$112.98K-169.0%
Q3 FY2022Sep 30, 2022-$122.44K–
Q4 FY2021Dec 31, 2021$152.24K+866.0%
Q3 FY2021Sep 30, 2021-$3.16K–
Q2 FY2021Jun 30, 2021$163.82K–
Q1 FY2021Mar 31, 2021-$106.88K–
Q4 FY2020Dec 31, 2020$15.76K–
Q3 FY2020Sep 30, 2020-$114.33K–
Q2 FY2020Jun 30, 2020-$2.80K–
Q1 FY2020Mar 31, 2020-$120.27K–
Q4 FY2019Dec 31, 2019-$107.66K–
Q3 FY2019Sep 30, 2019-$126.74K–
Q2 FY2019Jun 30, 2019-$129.32K–
Q1 FY2019Mar 31, 2019-$136.44K–
Q4 FY2018Dec 31, 2018-$143.60K-155.9%
Q3 FY2018Sep 30, 2018-$128.65K–
Q2 FY2018Jun 30, 2018-$121.78K–
Q1 FY2018Mar 31, 2018-$164.94K–
Q4 FY2017Dec 31, 2017$257.01K–
Q3 FY2017Sep 30, 2017-$127.10K–
Q2 FY2017Jun 30, 2017-$299.44K–
Q1 FY2017Mar 31, 2017-$140.22K–
Q4 FY2016Dec 31, 2016-$138.80K–
Q3 FY2016Sep 30, 2016-$187.35K–
Q2 FY2016Jun 30, 2016-$158.30K–

More Skinvisible figures

See a number that looks wrong?